LTG logo
LTG formerly London Toxicology Group Home   Officers   Contact us   Links   Disclaimer
microgenics Altrix
 
 
 

Drug monographs

drug monographs | EMCDDA | review articles | members posters | members publications | guidelines | Syva Drug Monitor | search


records: 1 - 4

Analytical profiles of the beta keto amphetamines (bkMDMA, bkMDEA, and bkMBDB)
view pdf filepdf file viewed: 27
author: Susannah Davies

GC/MS data are presented for betaketo derivatives of MDMA, MDEA and MBDB. These compounds are not controlled drugs in the UK.


Analytical profiles of the hallucinogenic amphetamines DOB, DOC and DOI.
view pdf filepdf file viewed: 488
author: Susannah Kenyon

GC/MS data are presented for three potent hallucinogenic amphetamines. One of them (DOC) has recently been found on a paper tab similar to those used for LSD. Certified rererence material is not available for this compound.


Bupropion Monograph
view pdf filepdf file viewed: 533
author: Simon Elliott

Historically, bupropion (amfebutamone) has been available in the U.S. as an antidepressant (Wellbutrin®). It is structurally unrelated to other antidepressants but has a therapeutic efficacy similar to tricyclic antidepressants. However, it has recently been prescribed in the U.K. as a smoking cessation adjunct (Zyban®). It is not prescribed in the U.K. as an antidepressant.


Analytical profiles of the piperazines; revised Feb 2007.
view pdf filepdf file viewed: 535
author: Susannah Kenyon

This monograph presents brief analytical profiles of the piperazine derivatives found in “illicit” tablets and capsules in the UK. Not all the compounds listed have been found in products but are presented because they are positional isomers of those that have.


records: 1 - 4